Lan-Xiang Wu (Lanxiang Wu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Top Venues

Cancer gene therapy

Molecular omics

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yutang Huang, Xiaoqing Wang, Chunjie Wen, Jingchan Wang, Honghao Zhou, Lan-Xiang Wu
Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis. MedComm 5 (8) (2024)
Wei-Feng Xia, Xiao-Li Zheng, Wen-Yi Liu, Yu-Tang Huang, Chun-Jie Wen, Hong-Hao Zhou, Qing-Chen Wu, Lan-Xiang Wu
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer gene therapy (2024)
Wei-Feng Xia, Xiao-Li Zheng, Wen-Yi Liu, Yu-Tang Huang, Chun-Jie Wen, Hong-Hao Zhou, Qing-Chen Wu, Lan-Xiang Wu
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer gene therapy 31 (5) (2024)
Yutang Huang, Xiaoqing Wang, Chunjie Wen, Jingchan Wang, Honghao Zhou, Lan-Xiang Wu
Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis. MedComm 5 (8) (2024)
Wei-Feng Xia, Xiao-Li Zheng, Wen-Yi Liu, Yu-Tang Huang, Chun-Jie Wen, Hong-Hao Zhou, Qing-Chen Wu, Lan-Xiang Wu
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer gene therapy 31 (5) (2024)
Nan Wang, Qilin Zhao, Yutang Huang, Chunjie Wen, Yaji Li, Meihua Bao, Lan-Xiang Wu
Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Molecular omics (2023)
Shuai He, Jingjing Shi, HongHao Zhou, Qingling Li, Lan-Xiang Wu
Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS region. Cancer gene therapy 29 (11) (2022)
Yutang Huang, Yan Du, Yujie Zheng, Chunjie Wen, Hecun Zou, Jiafeng Huang, Honghao Zhou, Hongbo Zhao, Lan-Xiang Wu
Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation. Cell death & disease 13 (6) (2022)